Investor's Business Daily on MSN
The gene-editing news that sent beleaguered Intellia Therapeutics stock up
Intellia Therapeutics stock surged Tuesday after the FDA aid it would allow the company to restart a gene-editing study.
News Medical on MSN
First topical CRISPR gene therapy corrects disease-causing mutations in human skin
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
Intellia is instituting new safeguards following the death of a study participant that led regulators to pause two trials in ...
A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly for life, according to a small early study released Saturday. The study, which ...
Morning Overview on MSN
Gene editing breakthrough could kill off daily cholesterol pills
For decades, high cholesterol has meant a lifetime of daily pills, repeat blood tests and constant reminders that the biggest ...
Caffeine could act as an on-off switch for gene and cell therapies, giving doctors more precise control over powerful ...
Precision DNA editing gene therapy achieves deep remissions in aggressive leukemia previously considered incurable.
TEK IMAGE/Science Photo Library / Getty Images/Science Photo Libra A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly for life, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results